the combination of a threshold dose of forskolin with a threshold dose of the camp-selective phosphodiesterase ( pde ) inhibitor rolipram resulted in a marked , statistically significant enhancement of the behavioral , hypothermic and brain camp elevating effect .
C0004927
behavioral
C0006104
brain